financetom
Business
financetom
/
Business
/
Update: GMS Shares Fall After Fiscal Q3 Results Miss Consensus
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: GMS Shares Fall After Fiscal Q3 Results Miss Consensus
Mar 6, 2025 8:34 AM

11:14 AM EST, 03/06/2025 (MT Newswires) -- (Updates with recent share movement in the headline and first paragraph.)

GMS (GMS) shares dropped 10% in recent Thursday trading after the company reported fiscal Q3 results that fell short of market expectations.

The distributor of specialty building products reported fiscal Q3 adjusted earnings Thursday of $0.92 per diluted share, down from $1.70 a year earlier.

Analysts polled by FactSet expected $1.40.

Net sales for the quarter ended Jan. 31 were $1.26 billion, roughly unchanged compared with a year earlier.

Analysts surveyed by FactSet expected $1.29 billion.

Price: 70.68, Change: -8.13, Percent Change: -10.32

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bruker Launches $600 Million Mandatory Convertible Preferred Stock Offering
Bruker Launches $600 Million Mandatory Convertible Preferred Stock Offering
Sep 2, 2025
04:26 PM EDT, 09/02/2025 (MT Newswires) -- Bruker ( BRKR ) said late Tuesday it launched a public offering of $600 million in mandatory convertible preferred stock, series A. Underwriters were granted a 30-day option to buy up to an additional $90 million to cover over-allotments. The offering includes 2.4 million shares, rising to 2.76 million if the option is...
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,557,649, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,557,649, According to a Recent SEC Filing
Sep 2, 2025
04:21 PM EDT, 09/02/2025 (MT Newswires) -- Tolga Tanguler, Executive Vice President, Chief Commercial Officer, on August 29, 2025, sold 3,474 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,557,649. Following the Form 4 filing with the SEC, Tanguler has control over a total of 25,992 common shares of the company, with 25,992 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1178670/000173527625000094/xslF345X05/edgardoc.xml ...
Zscaler Fiscal Q4 Adjusted Earnings, Revenue Rise; Issues Outlook
Zscaler Fiscal Q4 Adjusted Earnings, Revenue Rise; Issues Outlook
Sep 2, 2025
04:22 PM EDT, 09/02/2025 (MT Newswires) -- Zscaler ( ZS ) reported fiscal Q4 adjusted earnings late Tuesday of $0.89 per diluted share, up from $0.72 a year earlier. Analysts polled by FactSet expected $0.80. Revenue for the quarter ended July 31 was $719.2 million, up from $592.9 million a year earlier. Analysts surveyed by FactSet expected $706.9 million. The...
GitLab Appoints Manav Khurana as Chief Product, Marketing Officer; Manu Narayan as Chief Information Officer
GitLab Appoints Manav Khurana as Chief Product, Marketing Officer; Manu Narayan as Chief Information Officer
Sep 2, 2025
04:24 PM EDT, 09/02/2025 (MT Newswires) -- GitLab ( GTLB ) said late Tuesday it has appointed Manav Khurana as chief product and marketing officer and Manu Narayan as chief information officer. Khurana previously worked as the chief product officer at New Relic, while Narayan served as the vice president of business technology at Confluent, the company said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved